Development of a generic approach for highly selective delivery of therapeutics for cancer treatment

Emily MillsStudent: Emily Mills
Supervisor: Dr Yu-Hsuan Tsai
Location: Cardiff University
Cancer Type: All – Cancer drug delivery
Start and End Date: Oct 2017 – Sep 2020

Most cancer drugs are not very selective and often cause adverse side effects in the body. Consequently, chemotherapy can be an unbearable experience for patients. We intend to improve cancer outcome and patient experience by developing an approach allowing therapeutics to be selectively targeted to only cancer but not normal cells, leading to minimum side effects and better treatment experience.

We will also develop an outreach activity in the form of theatre production with Concert Theatre to emphasise on cancer prevention by healthy lifestyle. We will work with communities and tour the production in Wales.

<< Go Back